Pay in 4 interest-free payments of $6.60 Learn more
Ships within 48 hours · Estimated delivery Aug 14 - Aug 19
Category S0 (non-approved substances) covers pharmacological compounds without approval by any regulatory agency for use in humans
These include temporary skin redness, itch, or irritation after topical application, reported in a small percent of users, single-digit percentages in trials
It is not available on NHS prescription and has not been evaluated by NICE for any clinical indication
Tirzepatide (GLP-1/GIP) Tirzepatide is a first-in-class dual GIP (glucose-dependent insulinotropic polypeptide) and GLP-1 receptor agonist, providing synergistic metabolic effects for diabetes and obesity research
US$ 28.89
US$ 27.78
US$ 29.14
US$ 24.41
US$ 26.59
US$ 22.05
US$ 29.22
US$ 27.09
US$ 23.44
US$ 29.44
US$ 29.17
